Proton Therapy Expansion LHP specializes in turnkey proton therapy solutions through a P3 model, offering financing, development, management and operational expertise. This positions them to partner with hospitals seeking to adopt or expand proton therapy capabilities, highlighting cross-sell opportunities for financing, project management, and operations optimization.

Operational Analytics The company emphasizes data and analytics driven models and proprietary operational analytics. Sales opportunities exist to provide analytics software, data integration services, and performance benchmarking to optimize proton therapy centers and reduce risk and cost per treatment.

Educational Partnerships A history of educational initiatives and collaborations with AAMD and dosimetry education programs indicates a potential for training contracts, continuous education offerings, and certification partnerships that could be bundled with center deployments.

Strategic Alliances Past and ongoing partnerships with health networks and vendors (Froedtert MCW, MedLever, Applied Radiation Oncology) suggest opportunities to pursue co-development, feasibility studies, and joint ventures with health systems seeking proton therapy integration.

Financial and Scale Readiness With revenue in the low millions and a small employee base, LHP appears agile yet financially lean, implying an avenue to pitch financing-heavy deals, turnkey centers, and scalable operation models to healthcare systems evaluating proton therapy investments.